Erratum Statement on our communication relating to the new European authorization of Hy-D®

In our Nutri.Mail of 25/04/2024 on the latest developments on the legislation with respect to the new European approval of Hy-D® among other products unfortunately a redactional error was made. In this message it was wrongfully stated that the common use of Hy-D® with other sources of 1,25 (OH)2cholecalciferol from Solanum glaucophylum (eg. Panbonis) is prohibited by law.

However, this is not correct. The EU 2024/1070 statement does not refer to "Solanum glucophylum" itself, but explicitely to Solanum glaucophylum extract.

The correct phrasing should have been:
Please be aware that the European Commission specifies in the conditions of application that the common use of Hy-D® with glycosilated met 1,25 dihydroxycholecalciferol derived from Solanum glaucophylum extract is not allowed.

Therefore, in contrast to what we previously stated, Panbonis can be applied in combination with Hy-D® in poultry, swine and ruminants.”